Skip to content
MedsAcross

Manufacturer

Actelion Pharmaceuticals

Products listed
21
Molecules
6
Therapy areas
3

Actelion Pharmaceuticals is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 21 of its products across 6 molecules, each with registers, packs and availability for export supply to licensed buyers.

Indian manufacturer
No
Also listed as
Actelion Pharmaceuticals US, Inc.
US FDA labeler
YesSource: openFDA NDC directory

Source from this manufacturer

We supply Actelion Pharmaceuticals products through licensed channels, with the documents your regulator needs.

Haematology

14 presentations

Haematology overview
MedicineActive ingredientRegisterAvailability
Uptravi 100 mcg tabletOral Cold chainSelexipagUS FDAAvailable on request
Uptravi 1000 mcg tabletOral Cold chainSelexipagUS FDAAvailable on request
Uptravi 1200 mcg tabletOral Cold chainSelexipagUS FDAAvailable on request
Uptravi 1400 mcg tabletOral Cold chainSelexipagUS FDAAvailable on request
Uptravi 150 mcg tabletOral Cold chainSelexipagUS FDAAvailable on request
Uptravi 1600 mcg tabletOral Cold chainSelexipagUS FDAAvailable on request
Uptravi 1800 mcg/10 mL powder for injectionIntravenous Cold chainSelexipagUS FDAAvailable on request
Uptravi 200 mcg tabletOral Cold chainSelexipagUS FDAAvailable on request
Uptravi 400 mcg tabletOral Cold chainSelexipagUS FDAAvailable on request
Uptravi 600 mcg tabletOral Cold chainSelexipagUS FDAAvailable on request
Uptravi 800 mcg tabletOral Cold chainSelexipagUS FDAAvailable on request
UPTRAVI Titration Pack kit Cold chainSelexipagUS FDAAvailable on request
Veletri 0.5 mg/10 mL powder for injectionIntravenousEpoprostenolUS FDAAvailable on request
Veletri 1.5 mg/10 mL powder for injectionIntravenousEpoprostenolUS FDAAvailable on request

Cardiology

6 presentations

Cardiology overview
MedicineActive ingredientRegisterAvailability
Opsumit 10 mg tabletOralMacitentanUS FDAAvailable on request
Opsynvi 10 mg/20 mg tabletOralMacitentan and TadalafilUS FDAAvailable on request
Opsynvi 10 mg/40 mg tabletOralMacitentan and TadalafilUS FDAAvailable on request
Tracleer 125 mg tabletOralBosentanUS FDAAvailable on request
Tracleer 32 mg tablet for oral suspensionOralBosentanUS FDAAvailable on request
Tracleer 62.5 mg tabletOralBosentanUS FDAAvailable on request

Rare diseases and enzyme replacement

1 presentation

Rare diseases and enzyme replacement overview
MedicineActive ingredientRegisterAvailability
Zavesca 100 mg capsuleOralMiglustatUS FDAAvailable on request

Molecules made

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from Actelion Pharmaceuticals

Send a request for any of these products. We confirm the licensed source, documents and lead time.